Catalyst Event
Johnson & Johnson (JNJ) · Other
From Akros SCHK HK-U.S. Momentum Factor Index (ASHUMOM)
4/27/2026, 12:00:00 AM
On April 27, 2026, the FDA granted Priority Review for IMAAVY (nipocalimab) for the treatment of warm autoimmune hemolytic anemia (wAIHA), a rare blood disorder.
Korean Translation
2026년 4월 27일, 희귀 혈액 질환인 온난 자가면역 용혈성 빈혈(wAIHA) 치료를 위한 IMAAVY(니포칼리맙)가 FDA로부터 우선 심사 대상으로 지정됨.
Related Recent Events
Sinotruk (Hong Kong) Ltd (3808) · Other
Ex-dividend date for the final dividend of HKD 0.88 per share for the year 2025 is scheduled for 2026-07-09; medium importance is expected.
7/9/2026, 12:00:00 AM
PetroChina Company Limited (857) · Other
Ex-dividend date for final 2025 dividend of RMB 0.25 per share on June 18, 2026. The dividend was announced on March 29, 2026, and is scheduled to be paid on July 31, 2026. High importance estimated due to significant dividend yield scheduled.
6/18/2026, 12:00:00 AM
Jiangxi Copper Co Ltd (358) · Other
Ex-dividend date on June 11, 2026, for the final dividend of CNY 0.60 per share for the fiscal year 2025, with payment scheduled for July 17, 2026. Low importance is estimated as the dividend is expected to cause a ≥1% price impact.
6/11/2026, 12:00:00 AM
Hong Kong and China Gas Company Limited (3) · Other
Ex-dividend date on 2026-06-03 for the proposed final dividend of HK$0.23 per share for the year ended December 31, 2025, estimated 1% impact from standard dividend price adjustment, scheduled.
6/3/2026, 12:00:00 AM
Corning Inc (GLW) · Other
Corning declared a quarterly dividend of $0.28 per share. The ex-dividend date is May 29, 2026.
5/29/2026, 12:00:00 AM
Biocytogen Pharmaceuticals (Beijing) Co Ltd (2315) · Other
Annual General Meeting to be held on 2026-05-21 to review reports and approve plans; routine meetings typically have a 1-5% price impact, scheduled
5/21/2026, 12:00:00 AM